Overview
| MMP9 Protein | |
|---|---|
| **Protein Name** | Matrix Metalloproteinase-9 |
| **Gene Symbol** | MMP9 |
| **UniProt ID** | P14780 |
| **Molecular Weight** | 92 kDa (proenzyme), 82 kDa (active) |
| **Subcellular Localization** | Extracellular, secreted |
| **Protein Family** | Matrix metalloproteinase family |
| Drug | Mechanism |
| Marimastat | Broad MMP inhibitor |
| Ilomastat | Selective inhibitor |
| [Neprilysin](/entities/neprilysin) | MMP9 substrate |
| Disease | MMP-9 Level |
| AD | Elevated |
| PD | Elevated |
| ALS | Variable |
| MS | Elevated |
| Associated Diseases | ALI, ALS, ALZHEIMER, ALZHEIMER'S DISEASE, AMI |
| KG Connections | 1092 edges |
Mmp9 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
Mmp9 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. 4MMP9 in brain injury and repairOpen reference
The MMP9 protein (Matrix Metallopeptidase 9), also known as gelatinase B, is a zinc-dependent endopeptidase that degrades extracellular matrix proteins. It plays important roles in neuroinflammation and blood-brain barrier remodeling in neurodegenerative diseases. 5MMP9 in Alzheimer's diseaseOpen reference
Protein Overview
Structure
MMP9 has a characteristic MMP domain structure:
-
Signal peptide: Secretory pathway
-
Propeptide: Keeps enzyme inactive
-
Catalytic domain: Zn²⁺-dependent protease domain
-
Hemopexin domain: Substrate specificity
Normal Function
MMP9 is a key extracellular protease:
-
ECM degradation: Cleaves collagen IV, gelatin, elastin
-
Cell migration: Facilitates immune cell movement
-
Cytokine processing: Activates pro-inflammatory cytokines
-
Synaptic plasticity: Remodels synaptic proteins
Expression in Brain
MMP9 is expressed in:
Role in Disease
Alzheimer’s Disease
-
Elevated in AD brains and CSF
-
Contributes to BBB disruption
-
Degrades Aβ but may create toxic fragments
-
Therapeutic: MMP9 inhibitors
Parkinson’s Disease
-
Upregulated in substantia nigra
-
Contributes to neuroinflammation
-
Affects dopaminergic neurons
Stroke
-
Rapidly induced after ischemia
-
Causes BBB breakdown
-
Therapeutic target
Multiple Sclerosis
-
Promotes demyelination
-
Immune cell infiltration
Therapeutic Targeting
Key Publications
-
Brkic M, et al. (2015). MMPs in neurodegeneration. Progress in Neurobiology. 1CitationOpen reference(https://pubmed.ncbi.nlm.nih.gov/25481062/)
-
Yong VW, et al. (2001). The promise of MMP9 inhibitors. Nature Reviews Neuroscience. 2CitationOpen reference(https://pubmed.ncbi.nlm.nih.gov/11729114/)
-
Rosenberg GA, et al. (2009). MMP9 in brain disease. Neurochemical Research. 3CitationOpen reference(https://pubmed.ncbi.nlm.nih.gov/18759440/)
Pathway & Interaction Diagram
Interactive diagram showing MMP9 key relationships in the SciDEX knowledge graph (15 connections shown).
flowchart TD
MMP9(["MMP9"])
Inflammation["Inflammation"]
Als["Als"]
Aging["Aging"]
Coronary_Artery_Disease["Coronary Artery Disease"]
Luteolin["Luteolin"]
neutrophil_extracellular_traps("neutrophil extracellular traps")
necroptosis("necroptosis")
autophagy("autophagy")
h_1acdd55e["h-1acdd55e"]
MMP9_IN_1{"MMP9-IN-1"}
GATA4(["GATA4"])
Akt_Mtor["Akt/Mtor"]
Mapk["Mapk"]
MMP9 -->|"therapeutic target"| Inflammation
MMP9 -->|"activates"| Als
MMP9 -->|"therapeutic target"| Als
MMP9 -->|"therapeutic target"| Aging
MMP9 -->|"biomarker for"| Coronary_Artery_Disease
Luteolin -.->|"downregulates"| MMP9
MMP9 -->|"participates in"| neutrophil_extracellular_traps
MMP9 -->|"associated with"| necroptosis
MMP9 -.->|"inhibits"| autophagy
h_1acdd55e -->|"therapeutic target"| MMP9
MMP9_IN_1 -.->|"inhibits"| MMP9
GATA4 -.->|"inhibits"| MMP9
Akt_Mtor -->|"upregulates"| MMP9
h_1acdd55e -->|"targets gene"| MMP9
MMP9 -->|"therapeutic target"| Mapk
style MMP9 fill:#006494,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0See Also
External Links
Molecular Mechanisms
MMP-9 operates through several molecular mechanisms in neurodegeneration:
Extracellular Matrix Remodeling
MMP-9 degrades various ECM components including gelatin (denatured collagen), elastin, and type IV collagen. This remodeling affects:
Proteolytic Processing
MMP-9 cleaves non-ECM substrates:
-
ProBDNF to mature BDNF*: Converts proneurotrophic proBDNF to mature BDNF, affecting synaptic plasticity
-
IL-1β activation: Potentiates inflammatory cytokine activity
-
TNF-α processing: Generates soluble TNF-α fragments
Signaling Pathway Modulation
MMP-9 influences signaling through:
-
Integrin receptor activation
-
Growth factor receptor cleavage
-
Cytokine and chemokine processing
Transcriptional Regulation
MMP-9 expression is tightly regulated at the transcriptional level:
Inducers
-
Pro-inflammatory cytokines (IL-1β, TNF-α, IL-6)
-
Oxidative stress
-
Growth factors (EGF, PDGF)
-
Hypoxia
Repressors
-
TIMP-1 (tissue inhibitor of metalloproteinases-1)
-
Glucocorticoids
-
Retinoic acid
Transcription Factors
-
AP-1 binding site
-
NF-κB elements
-
Sp1 sites
Biomarker Applications
MMP-9 has potential as a biomarker in neurodegenerative diseases:
Research Models
Key experimental approaches include:
-
MMP-9 knockout mice: Show altered synaptic plasticity and learning deficits
-
Zymography: Activity measurement in tissue and fluid samples
-
Inhibitor studies: Broad-spectrum and selective MMP-9 inhibitors
-
Conditional expression: Temporal control of MMP-9 upregulation
Overview
Mmp9 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Background
The study of Mmp9 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
Sister wikis (recently updated · no domain on this page)
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- test
- JGBO-I27: Top 10 GBO Questions for Prioritization
- JGBO-I27: Top 10 GBO Questions for Prioritization
- Design Brief: Beta-test Evaluation Protocol for SciDEX v2 Design Trajectories
- Andy — Showcase Findings (auto-curated)
- Kris — Showcase Findings (auto-curated)
Recent activity here
No recent events touching this page.